Munich - Delayed Quote EUR
OrganiGram Holdings Inc (0OG0.MU)
0.9650
-0.0080
(-0.82%)
At close: April 1 at 8:00:28 AM GMT+2
Loading Chart for 0OG0.MU
- Previous Close
0.9730 - Open
0.0000 - Bid 0.9400 x --
- Ask 0.9790 x --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 2.0050 - Volume
0 - Avg. Volume
26 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Feb 11, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 0OG0.MU
View MorePerformance Overview: 0OG0.MU
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
0OG0.MU
37.01%
S&P/TSX Composite index (^GSPTSE)
0.37%
1-Year Return
0OG0.MU
46.69%
S&P/TSX Composite index (^GSPTSE)
12.91%
3-Year Return
0OG0.MU
83.08%
S&P/TSX Composite index (^GSPTSE)
17.60%
5-Year Return
0OG0.MU
82.82%
S&P/TSX Composite index (^GSPTSE)
71.36%
Compare To: 0OG0.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.9650
-0.82%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.0535
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.9200
+20.59%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Mkt Cap undefined -
Industry -
5.62
+7.97%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.9200
0.00%
Mkt Cap EUR 340.492M
Industry Drug Manufacturers—Specialty & Generic
0.4375
+13.49%
Mkt Cap EUR 436.133M
Industry Drug Manufacturers—Specialty & Generic
4.2100
+9.21%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.7400
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2200
+15.79%
Mkt Cap EUR 74.529M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 0OG0.MU
View MoreValuation Measures
As of 4/25/2025
Market Cap
136.20M
Enterprise Value
112.74M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.98
Price/Book (mrq)
0.65
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--